Anixa Biosciences Inc
Financial highlights
| Metric | FY 10/31/25 | FY 10/31/24 | FY 10/31/23 | FY 10/31/22 | FY 10/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | — | $0.2 | $0.2 | — | $0.5 |
| Operating income | -$11.7 | -$13.8 | -$11.0 | -$13.9 | -$13.1 |
| Net income | -$10.9 | -$12.6 | -$9.8 | -$13.6 | -$13.0 |
| Cash Flow Statement | |||||
| Share repurchases | — | $<0.1 | — | — | — |
Shares outstanding 34.8M · Free float 42.1%
Annual filing data through FY ended October 31, 2025; float as of September 19, 2026.